Skip to content

Services

Four parts. Each one stands alone.

Most clients take the full scope, because the four constrain each other — a formula that is pharmacologically ideal and impossible to compress is not a solution. But each part can be engaged on its own if that is what you need.

01

Formulation blueprint

The specification itself: what goes in, at what dose, in what form, and why.

What it covers

  • Active selection with the salt or ester form specified, not just the ingredient name
  • Dose set against the evidence for the claim you intend to make, not the lowest defensible amount
  • Every pairing checked for synergy and antagonism, including absorption competition
  • Contraindications mapped against your intended population and common concomitant medication
  • Excipient system chosen for the active it has to carry, not the cheapest available

Deliverable

A line-by-line specification with rationale and references for each decision.

02

Manufacturability & scale-up

The constraints that only appear once the formula meets a real production line.

What it covers

  • Flow, compressibility and blend uniformity at your intended batch size
  • Hygroscopicity and the environmental controls your CMO will need to hold
  • Overages calculated to hold label claim through shelf life, not just at release
  • Excipient interactions that change disintegration or dissolution
  • Where a bilayer, a coating or a separate dose is the only way to keep the formula intact

Deliverable

A manufacturability assessment naming the risks and the specified mitigation for each.

03

Regulatory & label claims

Whether the formula is legal where you intend to sell it, and what you may say about it.

What it covers

  • Screening against permitted ingredient lists and dose ceilings in each target market
  • Identifying where a single formula cannot serve every market you want
  • Novel or restricted ingredients flagged before they become a filing problem
  • The claims your formula and dose can actually support in each jurisdiction
  • Label content requirements including warnings that the dose triggers

Deliverable

A market-by-market screen with the specific constraint and its source for each finding.

04

CMO sourcing & vendor QC

Finding people who can actually make it, and checking what they send you.

What it covers

  • Identifying manufacturers equipped for your dose form at your volume
  • Qualifying raw-material vendors on specification, not on price alone
  • Reading certificates of analysis for what they omit as much as what they state
  • Specifying the identity, assay and contaminant testing your product needs
  • Reviewing the technical terms of a manufacturing agreement before you sign it

Deliverable

A shortlist with the qualification criteria applied, and the specification pack to send them.

Markets covered

Specified against all three where you need all three.

FDAUnited States

DSHEA · 21 CFR 111

FSSAIIndia

Nutraceutical Regs. 2022 · Sch. VIII

EFSAEuropean Union

Art. 13.1 · Novel Foods

How an engagement runs